Link Between Apolipoproteins and Retinal Arteriosclerosis in a Population Undergoing Health Assessments
By
Xinghe Sun
Lijuan Guo
Hui Lv
Xian Zhang
Chaoqun Wu
Xiaohui Liu
June 17, 2026
Clinical Scorecard: Link Between Apolipoproteins and Retinal Arteriosclerosis in a Population Undergoing Health Assessments
At a Glance
Category Detail
Condition
Key Mechanisms
Target Population
Care Setting
Key Highlights
Retinal arteriosclerosis prevalence: 13.98% in males, 8.57% in females. Higher ApoB levels and ApoB/ApoA1 ratios in individuals with retinal arteriosclerosis. ApoB and ApoB/ApoA1 ratio independently associated with retinal arteriosclerosis. Significant associations found in adults ≥45 years, non-smokers, and non-hypertensive individuals. Potential for integrating apolipoprotein profiling into cardiovascular risk assessment.
Guideline-Based Recommendations
Diagnosis
Management
Add source attribution for the recommendation on apolipoprotein profiling.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Adults aged 18 to 79 years from a health examination cohort.
Integration of apolipoprotein levels in assessing cardiovascular risk.
Clinical Best Practices
Related Resources & Content